Aminocaproic acid, an antifibrinolytic agent, is a medication used to manage and treat acute bleeding disorders. This activity outlines the indications, mechanism of action, and contraindications for aminocaproic acid as a valuable agent in managing hyperfibrinolysis-induced hemorrhage. In addition, this activity will also highlight other key factors, including the adverse event profile, off-label indications, dosing, and monitoring, pertinent for the healthcare team members in managing patients with acute hyperfibrinolysis-induced hemorrhage and related conditions.

**Objectives:**
- Identify the mechanism of action of aminocaproic acid.
- Describe the adverse effects of aminocaproic acid.
- Summarize appropriate monitoring parameters for aminocaproic acid-induced toxicity.
- Review interprofessional team strategies for improving care coordination and communication to advance aminocaproic acid use and improve its outcomes.